2018
DOI: 10.3389/fphar.2018.00754
|View full text |Cite
|
Sign up to set email alerts
|

Network Intervention, a Method to Address Complex Therapeutic Strategies

Abstract: Objective: Network-based approaches emerged as powerful tools for studying complex diseases. Our intention in this article was to raise awareness of the benefits of new therapeutic strategy in biological networks context and provide an introduction to this topic.Methods: This article will discuss the rational for network intervention, and outline some of the important aspects of deciphering targets activities in the network and future embodiments of network intervention. We also present examples of network int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…The evolving method of network pharmacology provides such a paradigm, which aims at identifying compounds that regulate the activity of multiple targets in the impaired mechanisms network and deregulate interactions underlying a disease phenotype, either by targeting multiple pathways or by reducing potential adverse effects (28, 29). In such a network environment, therapeutic response can be taken into account from the robustness of complex disease networks to deal with node attacks, due to the inherent diversity and redundant compensation signaling pathways that result in highly resilient network systems with topological interactions (30). Specific intervention concepts for network targeting reveal the complex mechanisms of drug action, suggesting that the effects of small molecule compounds may have multifactorial interventions on different targets (31).…”
Section: Discussionmentioning
confidence: 99%
“…The evolving method of network pharmacology provides such a paradigm, which aims at identifying compounds that regulate the activity of multiple targets in the impaired mechanisms network and deregulate interactions underlying a disease phenotype, either by targeting multiple pathways or by reducing potential adverse effects (28, 29). In such a network environment, therapeutic response can be taken into account from the robustness of complex disease networks to deal with node attacks, due to the inherent diversity and redundant compensation signaling pathways that result in highly resilient network systems with topological interactions (30). Specific intervention concepts for network targeting reveal the complex mechanisms of drug action, suggesting that the effects of small molecule compounds may have multifactorial interventions on different targets (31).…”
Section: Discussionmentioning
confidence: 99%